Proof The Bible Is True

Advisers to the Centers for Disease Control and Prevention (CDC) last week recommended newly approved vaccines for respiratory syncytial virus (RSV) — despite concerns about the efficacy and safety of the new vaccines, potentially harmful interactions with the flu and COVID-19 vaccines and the unspecified cost for the vaccines.

 

In a three-day meeting that ended Friday, the CDC’s Advisory Committee on Immunization Practices (ACIP) also:

 

Read More: CDC Panel Recommends Pfizer Pneumococcal Vaccines for Infants, RSV Vaccines for Adults • Children’s Health Defense